Catalent | CTLT - Equity Capital And Reserves


Catalent reported $4.78B in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.



Equity Capital And Reserves Change Date
Agilent USD 6.74B 371M Sep/2025
AstraZeneca USD 48.67B 2.78B Dec/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Bruker USD 2.49B 625.6M Sep/2025
Centene USD 19.95B 995M Dec/2025
Charles River Laboratories USD 3.41B 52.13M Sep/2025
Cigna USD 41.8B 1.38B Sep/2025
Danaher USD 52.53B 1.46B Dec/2025
Dentsply International USD 1.48B 482M Sep/2025
Elevance Health USD 44.03B 73M Dec/2025
Eli Lilly USD 26.54B 2.74B Dec/2025
Glaxosmithkline GBP 21.7B 7.35B Sep/2025
Hologic USD 5.25B 197.2M Dec/2025
Humana USD 17.66B 865M Dec/2025
Illumina USD 2.72B 342M Dec/2025
Intuitive Surgical USD 17.82B 894.3M Dec/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
J&J USD 78.47B 0 Sep/2025
Laboratory Of America USD 8.71B 240.3M Sep/2025
Lonza CHF 9.33B 23M Dec/2024
McKesson USD -1.3B 441M Dec/2025
Merck EUR 28.94B 677M Sep/2025
Merck USD 51.85B 2.79B Sep/2025
Mettler Toledo International USD -23.64M 225.56M Dec/2025
Novartis USD 44.75B 2.7B Sep/2025
Pfizer USD 92.8B 4.11B Sep/2025
Quest Diagnostics USD 7.17B 88M Dec/2025
Repligen USD 442.96M 1.62B Sep/2025
Revvity USD 7.38B 180.27M Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025
Supernus Pharmaceuticals USD 1.05B 14.23M Sep/2025
Thermo Fisher Scientific USD 53.54B 2.38B Dec/2025
UnitedHealth USD 105.81B 1.03B Sep/2025
Waters USD 2.33B 170.88M Sep/2025
West Pharmaceutical Services USD 3.18B 124.5M Dec/2025